Back to Trades
Total Value
$NaN
Filing Date
Jul 23, 2026
1 transactions
Trade Summary
On Jul 23, 2026, Aghazadeh Behzad, Director, reported $NaN of Scribe Therapeutics, Inc. (SCTX) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Scribe Therapeutics, Inc.
- Ticker Symbol
- SCTX
- CIK
- 0001853921
Insider Information
- Name
- Aghazadeh Behzad
- Role
- Director
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Jul 23, 2026
- Transaction Date
- Jul 23, 2026
- Accession Number
- 0000902664-26-003226
- Form Type
- 3
Want live alerts when Aghazadeh Behzad trades again?
Download Insider Trades to track SCTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The securities reported herein are held on behalf of accounts managed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"). Behzad Aghazadeh ("Dr. Aghazadeh") serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures", and together with Avoro Capital Advisors and Dr. Aghazadeh, the "Reporting Persons").
- (F2)The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.